Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ti-Ventures SA is a seed investment fund established in 2016 and based in southern Switzerland. The fund is owned by the Fondazione Centenario Banca Stato and focuses on investing in early-stage companies that possess innovative technologies and high growth potential. The organization primarily operates in the life sciences, medical technology, high-tech, and IT sectors.
Since its inception, Ti-Ventures has aimed to foster economic growth and innovation in the Ticino region by collaborating with local universities, the state government, and other stakeholders. The firm has built a diversified portfolio that includes notable companies and has established itself as a key player in the early-stage investment landscape in Switzerland.
As of now, Ti-Ventures has a strong presence in the venture capital ecosystem, actively engaging with startups and stakeholders. The firm continues to seek opportunities that align with its investment thesis, focusing on sectors that promise significant advancements and returns.
Ti-Ventures invests in early-stage companies located in Ticino, Switzerland, with a strong emphasis on sectors such as life sciences, medical technology, high-tech, and information technology. The fund primarily targets investments at the pre-seed, seed, and Series A stages, allowing it to support companies from their inception through early growth phases.
The investment strategy is centered around identifying innovative technologies that demonstrate high growth potential. Ti-Ventures collaborates closely with local universities and the state government to enhance regional economic growth and innovation. This collaboration not only provides startups with valuable resources but also strengthens the local entrepreneurial ecosystem.
Ti-Ventures looks for founders who possess a strong vision and the ability to execute their ideas effectively. The firm values innovative approaches and technologies that can disrupt existing markets or create new ones. Deal structures are typically flexible, allowing for tailored arrangements that suit the needs of both the fund and the startups.
Ti-Ventures has a diversified portfolio that includes notable companies such as:
This portfolio reflects Ti-Ventures' commitment to supporting innovative companies that are poised for growth and success in their respective fields.
Lorenzo Leoni: Managing Partner with extensive experience in venture capital and a background in technology investments.
Paolo Orsatti: Managing Partner who has a strong track record in early-stage investments and a focus on life sciences.
Roberto Grassi: President of the Board of Directors, bringing leadership experience from various investment firms.
Sergio Magistri: Member of the Board of Directors with expertise in corporate governance and strategic planning.
Davide Mottis: Member of the Board of Directors, known for his insights into technology and innovation.
To pitch Ti-Ventures, founders should visit their website at tiventures.ch. The pitch deck should include a clear overview of the business model, market opportunity, and team qualifications. Ti-Ventures prefers detailed business plans that outline the technology and its potential impact.
Response times can vary, but founders should expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In 2021, Ti-Ventures celebrated the public listing of its portfolio company, Gain Therapeutics, on NASDAQ. This milestone marked a significant achievement for the firm and its investment strategy.
In 2022, xFarm successfully completed a Series B funding round, demonstrating the ongoing growth and potential of its agricultural technology solutions. A Series C round is planned for 2024, indicating continued investor interest.
Additionally, Ti-Ventures remains active in the venture capital ecosystem, regularly engaging with startups and stakeholders to identify new investment opportunities.
What are Ti-Ventures' investment criteria?
Ti-Ventures focuses on early-stage companies in the life sciences, medical technology, high-tech, and IT sectors, particularly those located in Ticino, Switzerland. The fund seeks innovative technologies with high growth potential.
How can I apply or pitch to Ti-Ventures?
Founders can submit their pitches through the Ti-Ventures website at tiventures.ch. It is advisable to include a detailed business plan and information about the team and technology.
What makes Ti-Ventures different from other investors?
Ti-Ventures emphasizes collaboration with local universities and government entities, which enhances its ability to support startups in the Ticino region. This local focus allows for tailored support and resources.
What is the geographic scope of Ti-Ventures' investments?
The firm primarily invests in early-stage companies located in Ticino, Switzerland, but may consider opportunities in other parts of Europe that align with its investment thesis.
What is the typical fund size and check size for Ti-Ventures?
While specific fund sizes are not disclosed, Ti-Ventures typically invests at the seed, pre-seed, and Series A stages, which generally involves check sizes that align with early-stage funding needs.
What kind of post-investment involvement does Ti-Ventures have?
Ti-Ventures actively engages with its portfolio companies, providing mentorship, resources, and support to help them achieve their growth objectives. The firm often takes board positions to guide strategic decisions.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.